abstract |
Disclosed is the use of compound 1-(4-chlorophenyl)-4-piperidinoimidazolin-2-one for the manufacture of a medicament for treating or preventing a central nervous system disorder, wherein the central nervous system disorder is an anxiety disorder or episode of anxiety in a patient. |